Fund VI


Size: EUR 1,900 million

Year: 2006

Investment focus/criteria:

Geographic scope:Primarily Nordic Region, selected investments in Europe Industries:Diversified, special focus on and expertise in healthcare investments Main focus:Large and medium-sized companies Key Characteristics:Opportunities for structural transformation, operational improvements, buy & build, emerging market growth, strategic repositioning, international expansion and growth acceleration.


Investors:

Investors in Nordic Capital Funds are 60 institutions, e.g. pension funds, banks and insurance companies. 

The Nordic region represents 20% of committed capital, Europe 30%,
the US 40% and rest of the world 10%.


General Partner Board of Directors:
Andrew Bennett
Jean Le Creurer
Lynda Elliott
Keith Mackenzie
David Pirouet

Investments:
Investment year Company Industry Turnover (EUR m)* Exit
2005 Luvata > Metal solutions manufacturing and heat transfer technology 1625
2005 Nycomed Pharmaceuticals 2011
2006 Fougera Pharmaceuticals Inc. (formerly Nycomed US Inc.) Specialty pharmaceuticals 2012
2006 Brightpoint Mobile phone distributor 2007
2006 Menigo > Food service distributor 543
2006 Capio > Healthcare services 1210
2007 Unilabs > Laboratory and radiology services 621
2007 Thule > Leisure, outdoor industry 666
2007 Nefab > Packaging solutions provider 347
2008 ConvaTec > Ostomy, wound care and hospital products 1309
2008 Chromaflo Technologies (Combination with CPS Color’s Colorant division) > Colorant systems 300
2008 Corob (Former CPS Color's Equipment business) > Colorant equipment 78

* 2012 sales for companies still in portfolio; sales at exit for divested companies


Contact information:

Nordic Capital Limited
26 Esplanade, St Helier Jersey JE2 3QA
Tel: +44 1534 605 100
Fax: +44 1534 605 199
For all investor communications: investor@nordiccapital.je